Thomas Goralski
Chief Operating Officer at Expression Analysis, Inc.
Thomas Goralski active positions
| Companies | Position | Start | End |
|---|---|---|---|
Expression Analysis, Inc.
 Expression Analysis, Inc. Medical SpecialtiesHealth Technology Expression Analysis, Inc. supplies microarray services and solutions for clinical trials. It provides experimental design consultation, biologic sample preparation, sample processing, and statistical analysis services. The company was founded in September, 2001 by Steven Casey and is headquartered in Durham, NC. | Chief Operating Officer | - | - |
Career history of Thomas Goralski
Former positions of Thomas Goralski
| Companies | Position | Start | End |
|---|---|---|---|
| Incyte Genomics Inc. /Micoarray Operations/ | Corporate Officer/Principal | - | - |
Perlegen Sciences, Inc.
 Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Corporate Officer/Principal | - | - |
Statistics
International
| United States | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 2 |
| Retail Trade | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Expression Analysis, Inc.
Expression Analysis, Inc. Medical SpecialtiesHealth Technology Expression Analysis, Inc. supplies microarray services and solutions for clinical trials. It provides experimental design consultation, biologic sample preparation, sample processing, and statistical analysis services. The company was founded in September, 2001 by Steven Casey and is headquartered in Durham, NC. | Health Technology |
Perlegen Sciences, Inc.
Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Retail Trade |
| Incyte Genomics Inc. /Micoarray Operations/ | Commercial Services |
- Stock Market
- Insiders
- Thomas Goralski
- Experience
